BORRELIA BURGDORFERI

Researchers find new treatment path for lasting Lyme disease symptoms

This discovery suggests that targeting FGFR pathways may offer an exciting new therapeutic approach to addressing persistent neuroinflammation in patients with post-treatment Lyme disease syndrome.